Table 4.
Functional outcomes
| Study | Number functional outcome | Follow-up (mo) | Function (preoperative) | Function (postoperative) |
|---|---|---|---|---|
| Nicol 2021 [19] | 14 | 60 ± 48 | NA | Oxford 33.6 ± 8.5 (21-47) |
| Lucchini 2021 [20] | 68 | 142 ± 19.2 (122–212) | HHS 37.6 ± 14.1 (15–70.5) | HHS 88.4 ± 11.6 (43.5–96.9) |
| Kumar 2021 [21] | 18 | 28 (12-60) | NA | HHS 89.72 ± 4.24 (82-95) |
| Kassem 2021 [22] | 45 | 124 (84-180) | Oxford 16.0 ± 4.12 (8-24) | Oxford 39.80 ± 3.08 (33-44) |
| Gracia 2021 [23] | 39 | 70 (24-132), ORIF 50 (24-132), Cons 90 (24-120) | NA | HHS 85 (60-95), ORIF 83 (60-90), Cons 86.9 (60-95). Oxford 40 (19-48) ORIF 39 (19-47) Cons 40.95 (19-47) |
| Moon 2020 [24] | 37 | 79 (24-145) | HHS 42.9 (17-70) | HHS 83.5 (29-97) |
| Busch 2020 [25] | 48 | 54 ± 23 (14–88) | NA | HHS 75.7 ± 21.3 (26.9–100) |
| Garcia Rey 2020 [26] | 78 | 133 (60-276), ORIF 122 (60-240), Cons 140 (60-276) | HHS 52.0 ORIF 50.2 ± 6.4 Cons 53.1 ± 4.9 | HHS 90.6 ORIF 89.5 ±10.5 Cons 91.3 ± 11.9 |
| Do 2020 [27] | 25 | 50 (24-222) | HHS 41 (18-47) | HHS 88 (77-100) |
| Taheriazam 2019 [28] | 49 | 44 (24-60) | HHS 47 (31-66) | HHS 89 (79-95) |
| Lee 2019 [29] | 57 | 94 ± 29 Min 5 years | UCLA Score 3.6 ± 1.3 | UCLA 4.9 ± 1.9 |
| Wang 2018 [30] | 33 | 138 ± 36 (96-204) | HHS 44.0 ± 11.9 (27-58) ORIF 45.9 ± 12.1 (27-58) Cons 40.8 ± 11.3 (29–58) | HHS 88.6 ± 5.1 (74-94) ORIF 89.0 ± 5.4 (74-94) Cons 87.9 ± 4.8 (79–94) |
| Salama 2017 [31] | 21 | 26 (24–36) | HHS 38 (0–70) | HHS 92 (75–100) ORIF 99 (75–100) Cons 85 (79–100) |
| Clarke-Jensson 2017 [32] | 39 | Median 88 (12-252) | HHS 53 ± 10 | HHS 82 ± 16, Pelvic Centre 88 ± 13, Non-specialist institution 75 ± 6 |
| Gavaskar 2017 [33] | 44 | ORIF 82 ± 117 Cons 85 ± 16 | Oxford ORIF 16.7 ± 2.8 Cons 9 ± 3.7 | Oxford ORIF 41.9 ± 3.1, Cons 41.5 ± 3.5 |
| Yuan 2015 [35] | 28 | 60 (25-120) | HHS 39 (3-71) | HHS 82 (21-100) |
| Schnaser 2014 [37] | 17 | 77 ± 33 | NA | HHS 70 ± 25 (19-95) |
| Lizaur Utrilla 2012 [38] | 24 | 101 (60-180) | HHS 35.1 ± 7.9 (22-52) | HHS 77 ± 16.5 (45-94) |
| Lai 2011 [39] | 31 | 76 (37–101) | HHS 49 ORIF 50 ± 16 Cons 48±12 | HHS 89 ± 5 ORIF 87 ± 6 Cons 91 ± 3 |
| Zhang 2011 [40] | 51 | 64 (32-123) | HHS 49.5 (22-78) ORIF 49.5 (30-78) Cons 54.3 (22-76) | NA |
| Ranawat 2009 [12] | 32 | 59 (48-116) | HHS 28 (0-56) | HHS 82 (20-100) ORIF 84 Cons 74 |
| Bellabarba 2001 [41] | 30 | 63 (24-140) | HHS 41 (19-55) ORIF 40 (29-55) Cons 41 (19-52) | HHS 82 (20-100) ORIF 84 Cons 74 |
| Sarkar 2001 [42] | 22 | 48 (15-168) | NA | HHS Very Good 10, Good 3, Fair 2, Poor 7 |
| Huo 1999 [43] | 21 | 65 (48-104) | HHS 30 | HHS 90 |
| Weber 1998 [44] | 63 | 115 (24–240) | HHS 49 | NA |